Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
Clinical trial NCT02392793 · COMPLETED
Trial details
- NCT number
- NCT02392793
- Sponsor
- St. Jude Children's Research Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-25
- Primary completion
- 2019-02-20
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.